Orai channel pharmacological manipulation reduces metabolic flexibility in cardiac fibroblasts

Patricia Da Silva Pantoja Newman1, Amandeep Bajwa2, Agnese De Mario3

  • 1Department of Physiology, The University of Tennessee Health Science Center, Memphis, Tennessee, United States.

Insights

Orai calcium channels are vital for cardiac fibroblast energy production and organelle calcium balance. Inhibiting Orai disrupts cellular metabolism, impacting heart function and disease progression.

Area of Science:

  • Cardiovascular Biology
  • Cell Physiology
  • Metabolic Biochemistry

Background:

  • Cardiac fibroblasts (CFs) are key in heart function and disease remodeling.
  • Fibroblast metabolic alterations drive heart pathologies like hypertension and heart failure.
  • Calcium (Ca2+) signaling, mediated by ion channels, is critical for fibroblast functions.

Purpose of the Study:

  • To investigate the role of Orai Ca2+ channels in cardiac fibroblast organelle Ca2+ homeostasis.
  • To determine the impact of Orai channels on cellular energy production in CFs.
  • To elucidate the contribution of Orai-dependent Ca2+ entry to metabolic flexibility.

Main Methods:

  • Chronic and acute inhibition of Orai channel activity in cardiac fibroblasts.
  • Analysis of metabolic enzyme expression levels.
  • Measurement of Ca2+ content in the endoplasmic reticulum (ER) and mitochondria.
  • Assessment of cellular glucose utilization for energy production.

Main Results:

  • Chronic Orai inhibition altered major metabolic enzyme expression, impacting cell metabolism.
  • Orai channels are essential for refilling ER Ca2+ stores.
  • Acute Orai inhibition reduced ER and mitochondrial Ca2+, impairing glucose metabolism.

Conclusions:

  • Orai Ca2+ channels are crucial for maintaining organellar Ca2+ homeostasis and energy metabolism in cardiac fibroblasts.
  • Orai-dependent Ca2+ entry supports cellular metabolic flexibility.
  • These findings offer insights into fibrogenesis and potential therapeutic targets.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.1K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
401